- Home
- INBX vs GLO Comparison
INBX vs GLO Comparison
Compare INBX & GLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INBX
- GLO
- Stock Information
- Founded
- INBX 2010
- GLO 2006
- Country
- INBX United States
- GLO United States
- Employees
- INBX N/A
- GLO N/A
- Industry
- INBX Biotechnology: Pharmaceutical Preparations
- GLO Finance/Investors Services
- Sector
- INBX Health Care
- GLO Finance
- Exchange
- INBX Nasdaq
- GLO Nasdaq
- Market Cap
- INBX 190.2M
- GLO 220.0M
- IPO Year
- INBX 2020
- GLO N/A
- Fundamental
- Price
- INBX $12.56
- GLO $5.23
- Analyst Decision
- INBX Hold
- GLO
- Analyst Count
- INBX 1
- GLO 0
- Target Price
- INBX N/A
- GLO N/A
- AVG Volume (30 Days)
- INBX 88.8K
- GLO 170.5K
- Earning Date
- INBX 11-14-2024
- GLO 01-01-0001
- Dividend Yield
- INBX 6.77%
- GLO 11.38%
- EPS Growth
- INBX N/A
- GLO N/A
- EPS
- INBX 119.38
- GLO N/A
- Revenue
- INBX $1,568,000.00
- GLO N/A
- Revenue This Year
- INBX N/A
- GLO N/A
- Revenue Next Year
- INBX N/A
- GLO N/A
- P/E Ratio
- INBX $0.11
- GLO N/A
- Revenue Growth
- INBX 19.24
- GLO N/A
- 52 Week Low
- INBX $10.80
- GLO $4.08
- 52 Week High
- INBX $18.95
- GLO $5.18
- Technical
- Relative Strength Index (RSI)
- INBX 42.38
- GLO 43.62
- Support Level
- INBX $12.08
- GLO $5.23
- Resistance Level
- INBX $13.60
- GLO $5.32
- Average True Range (ATR)
- INBX 0.76
- GLO 0.05
- MACD
- INBX 0.05
- GLO -0.01
- Stochastic Oscillator
- INBX 20.87
- GLO 31.25
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.
About GLO Clough Global Opportunities Fund
Clough Global Opportunities Fund is a closed-end management investment company based in the United States. Its investment objective is to provide a high level of total return by investing in equity securities of companies of any market capitalization and equity-related securities, including equity swaps and call options, as well as fixed-income securities, including both corporate and sovereign debt, in both U.S. and non-U.S. markets.